Stocks · Technology · Services-Computer Programming, Data Processing, Etc.

Health Catalyst, Inc.

HCAT Clue Score36
United States Fiscal year ends December CIK 0001636422 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Simeon Kohl
14 Sep 2026
Chief Executive Officer
Buy
59,000
$1.79
$105.44K
Daniel D. Burton
27 Feb 2024
Chief Executive Officer
Buy
26,200
$7.81
$204.53K
Daniel D. Burton
12 May 2023
Chief Executive Officer
Buy
49,050
$10.19
$499.59K
Daniel D. Burton
11 Nov 2022
Chief Executive Officer
Buy
197,078
$10.14
$2.00M
Daniel D. Burton
8 Sep 2022
Chief Executive Officer
Buy
90,750
$10.99
$996.97K
Duncan Gallagher
19 Aug 2022
Director
Buy
6,600
$11.63
$76.75K
Duncan Gallagher
18 Aug 2022
Director
Buy
8,400
$11.69
$98.20K
Daniel D. Burton
9 Aug 2022
Chief Executive Officer
Buy
176,522
$11.62
$2.05M
Showing 250 of 403 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 514
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 236
Sales at will 87
Transactions with no price 0
Shares from compensation/vesting 42,547,408
Sales filed before the plan box existed 77
History held since 29 Jul 2019